clinical trial · NCT05051566
A Multiple Dose Study of LY3502970 in Healthy Participants
Eli Lilly and Company·phase1·completed·n = 26
HealthyLY3502970Esomeprazole
brief summary
The main purpose of this study is to assess how fast LY3502970 gets into the blood stream and how long it takes the body to remove it when administered in multiple oral doses as new formulation compared to that of reference LY3502970 formulation. Information about safety and tolerability will be collected. The study is open to healthy participants. The study is conducted in two parts and it will last up to about 6 months, inclusive of screening period.
started
Sep 16, 2021
primary completion
Apr 4, 2022
completion
Apr 4, 2022
last updated
May 29, 2026
official title
A Multiple Dose Study in Healthy Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol